
01.03.2021 • News
FDA Grants EUA for J&J’s Covid Vaccine
The US Food and Drug Administration (FDA) on 27 February granted an Emergency Use Authorization (EUA) to the Covid-19 vaccine developed by Janssen Biotech, part of US healthcare giant Johnson & Johnson’s pharmaceuticals arm. The “totality of the available data available data,” it said, provides “clear evidence” that the vaccine may be effective in preventing infection from the virus.